Aarkstore - Metastatic Biliary Tract Cancer - Pipeline Review, H2 2014

1
Metastatic Biliary Tract Cancer - Pipeline
Review, H2 2014
Category  Healthcare
2
Summary

• Metastatic Biliary Tract Cancer - Pipeline
  Review, H2 2014, provides an overview of the
  Metastatic Biliary Tract Cancers therapeutic
  pipeline.This report provides comprehensive
  information on the therapeutic development for
  Metastatic Biliary Tract Cancer, complete with
  comparative analysis at various stages,
  therapeutics assessment by drug target, mechanism
  of action (MoA), route of administration (RoA)
  and molecule type, along with latest updates, and
  featured news and press releases. It also reviews
  key players involved in the therapeutic
  development for Metastatic Biliary Tract Cancer
  and special features on late-stage and
  discontinued projects.

Browse Complete Report - http//www.aarkstore.com/
healthcare/89680/metastatic-biliary-tract-cancer-p
ipeline-review-h2-2014
3
Scope

• - The report provides a snapshot of the global
  therapeutic landscape of Metastatic Biliary Tract
  Cancer- The report reviews key pipeline products
  under drug profile section which includes,
  product description, MoA and RD brief, licensing
  and collaboration details other developmental
  activities - The report reviews key players
  involved in the therapeutics development for
  Metastatic Biliary Tract Cancer and enlists all
  their major and minor projects- The report
  summarizes all the dormant and discontinued
  pipeline projects - A review of the Metastatic
  Biliary Tract Cancer products under development
  by companies and universities/research institutes
  based on information derived from company and
  industry-specific sources- Pipeline products
  coverage based on various stages of development
  ranging from pre-registration till discovery and
  undisclosed stages

4
Reasons to buy

• - Provides strategically significant competitor
  information, analysis, and insights to formulate
  effective RD development strategies- Identify
  emerging players with potentially strong product
  portfolio and create effective counter-strategies
  to gain competitive advantage- Develop strategic
  initiatives by understanding the focus areas of
  leading companies- Identify and understand
  important and diverse types of therapeutics under
  development for Metastatic Biliary Tract Cancer-
  Plan mergers and acquisitions effectively by
  identifying key players of the most promising
  pipeline- Devise corrective measures for
  pipeline projects by understanding Metastatic
  Biliary Tract Cancer pipeline depth and focus of
  Indication therapeutics

5
Table of Content

• Introduction 5Global Markets Direct Report
  Coverage 5Metastatic Biliary Tract Cancer
  Overview 6Therapeutics Development 7Pipeline
  Products for Metastatic Biliary Tract Cancer -
  Overview 7Pipeline Products for Metastatic
  Biliary Tract Cancer - Comparative Analysis
  8Metastatic Biliary Tract Cancer - Therapeutics
  under Development by Companies 9Metastatic
  Biliary Tract Cancer - Pipeline Products Glance
  10Clinical Stage Products 10Metastatic Biliary
  Tract Cancer - Products under Development by
  Companies 11Metastatic Biliary Tract Cancer -
  Companies Involved in Therapeutics Development
  12AstraZeneca PLC 12GlaxoSmithKline plc
  13Novartis AG 14OncoTherapy Science, Inc. 15

6
List of Tables

• Number of Products under Development for
  Metastatic Biliary Tract Cancer, H2 2014 7Number
  of Products under Development for Metastatic
  Biliary Tract Cancer - Comparative Analysis, H2
  2014 8Number of Products under Development by
  Companies, H2 2014 9Comparative Analysis by
  Clinical Stage Development, H2 2014 10Products
  under Development by Companies, H2 2014
  11Metastatic Biliary Tract Cancer - Pipeline by
  AstraZeneca PLC, H2 2014 12Metastatic Biliary
  Tract Cancer - Pipeline by GlaxoSmithKline plc,
  H2 2014 13Metastatic Biliary Tract Cancer -
  Pipeline by Novartis AG, H2 2014 14Metastatic
  Biliary Tract Cancer - Pipeline by OncoTherapy
  Science, Inc., H2 2014 15Assessment by
  Monotherapy Products, H2 2014 16Assessment by
  Combination Products, H2 2014 17Number of
  Products by Stage and Target, H2 2014 19Number
  of Products by Stage and Mechanism of Action, H2
  2014

7
List of Figures

• Number of Products under Development for
  Metastatic Biliary Tract Cancer, H2 2014 7Number
  of Products under Development for Metastatic
  Biliary Tract Cancer - Comparative Analysis, H2
  2014 8Number of Products under Development by
  Companies, H2 2014 9Comparative Analysis by
  Clinical Stage Development, H2 2014 10Assessment
  by Monotherapy Products, H2 2014 16Number of
  Products by Top 10 Targets, H2 2014 18Number of
  Products by Stage and Top 10 Target, H2 2014
  19Number of Products by Top 10 Mechanism of
  Actions, H2 2014 20Number of Products by Stage
  and Top 10 Mechanism of Actions, H2 2014
  21Number of Products by Stage and Top 10 Routes
  of Administration, H2 2014 22Number of Products
  by Top 10 Molecule Types, H2 2014 23Number of
  Products by Stage and Top 10 Molecule Types, H2
  2014 24

8
Related Reports

• Pancreatitis Global Clinical Trials Review, H2,
  2014
• Onchocerciasis (River Blindness) Global Clinical
  Trials Review, H2, 2014
• Pediculosis (Head Lice Infestation) Global
  Clinical Trials Review, H2, 2014
• Severe Acute Respiratory Syndrome (SARS)
  Coronavirus Infection Global Clinical Trials
  Review, H2, 2014
• Urinary Tract Infections Global Clinical Trials
  Review, H2, 2014
• Vulvovaginal Candidiasis Global Clinical Trials
  Review, H2, 2014
• Pleural Effusion Global Clinical Trials Review,
  H2, 2014
• Febrile Neutropenia Global Clinical Trials
  Review, H2, 2014
• Respiratory Depression Global Clinical Trials
  Review, H2, 2014

9

• Metastatic Biliary Tract Cancer - Pipeline
  Review, H2 2014
• Published Dec 2014 48 Pages
• Metastatic Biliary Tract Cancer - Pipeline
  Review, H2 2014, provides an overview of the
  Metastatic Biliary Tract Cancers therapeutic
  pipeline.
• Price

Format Price
PDF 2000
Site Licence 4000
Enterprise Wide Licence 6000
10
Contact Us
Office Office No. - 809, 8th Floor,B-Wing,
Mahaavir Icon, Plot No.- 89 90,
Sector-15,CBD-Belapur, Navi Mumbai
400614, Maharashtra, India. Telefax No 91 22
4127 6660 24/7 Online Support 91
9987295242 General Inquiries 91 - 22 2756 4953

• You Can Visit http//www.aarkstore.com
• OR Mail us at contact_at_aarkstore.com
• Blog
• http//www.aarkstore.com/blog/
• Conference
• http//conference.aarkstore.com/
• News
• http//www.aarkstore.com/news